CD274 and neoplasm: revealed that tumor cell surface tumor-specific MUC1 glycoforms (MUC1-ST) bind to Siglec-9, activating myeloid cells to secrete key factors influencing tumor progression, induce macrophages to transform into tumor-associated macrophage (TAM) phenotypes, and increase PD-L1 expression (25).